AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin

#merck

Related Stories (2)

Exclusive: Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say - Reuters

Exclusive: Merck, rivals eye deal for Inhibrx experimental cancer drug tied to Keytruda, sources say Reuters

April 22, 2026

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports - Reuters

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports Reuters

March 25, 2026